NEW YORK ( TheStreet) -- Shares of Transition Therapeutics (Nasdaq: TTHI) have taken a tremendous swing upward. The stock is trading at $4.80 as of 9:42 a.m. ET, 34.5% above Friday's closing price of $3.57. Volume is at 244,416, 2.5 times the daily average of 96,800. Transition has a market cap of $82.9 million and is part of the health care sector and drugs industry. Shares are up 84% year to date as of the close of trading on Friday. Transition Therapeutics Inc., a biopharmaceutical company, develops novel therapeutics for various disease indications primarily in Canada. TheStreet Ratings rates Transition as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. You can view the full Transition Ratings Report. See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.
More from Markets
How to Play the Fed-Induced, President-Endorsed Steel Cycle, Says Cramer
Jim Cramer's got some investing advice when it comes to investing in steel.
Jim Cramer Says the Best Time to Buy a Hot, Expensive Stock Is When This Happens
Hint: He admits his strategy takes a lot of 'fortitude.'